These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33227300)

  • 1. PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young Female.
    Ramkumar RR; Murthy PB; Nguyen JK; McKenney J; Eng C; Campbell SC
    Urology; 2021 Feb; 148():113-117. PubMed ID: 33227300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome.
    Mester JL; Zhou M; Prescott N; Eng C
    Urology; 2012 May; 79(5):1187.e1-7. PubMed ID: 22381246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Neoplasia Occurring in Patients With PTEN Hamartoma Tumor Syndrome : Clinicopathologic Study of 12 Renal Cell Carcinomas From 9 Patients and Association With Intrarenal "Lipomas".
    Kozman D; Kao CS; Nguyen JK; Smith SC; Kehr EL; Tretiakova M; Przybycin CG; Williamson SR; Argani P; Eng C; Campbell SC; McKenney JK; Alaghehbandan R
    Am J Surg Pathol; 2023 Sep; 47(9):1001-1010. PubMed ID: 37357918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer.
    Shuch B; Ricketts CJ; Vocke CD; Komiya T; Middelton LA; Kauffman EC; Merino MJ; Metwalli AR; Dennis P; Linehan WM
    J Urol; 2013 Dec; 190(6):1990-8. PubMed ID: 23764071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
    Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
    Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?
    Mester JL; Moore RA; Eng C
    Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime cancer risks in individuals with germline PTEN mutations.
    Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
    Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma.
    Bennett KL; Campbell R; Ganapathi S; Zhou M; Rini B; Ganapathi R; Neumann HP; Eng C
    Genes Chromosomes Cancer; 2011 Aug; 50(8):654-61. PubMed ID: 21584899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol.
    Piccione M; Fragapane T; Antona V; Giachino D; Cupido F; Corsello G
    Am J Med Genet A; 2013 Nov; 161A(11):2902-8. PubMed ID: 24123798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Implications for Germline PTEN Spectrum Disorders.
    Ngeow J; Sesock K; Eng C
    Endocrinol Metab Clin North Am; 2017 Jun; 46(2):503-517. PubMed ID: 28476234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel dermatological and skeletal features associated with PTEN variant in PTEN hamartoma tumor syndrome.
    Comeau D; Allain V; Maillet-Lebel N; Ben Amor M
    Eur J Med Genet; 2023 Aug; 66(8):104798. PubMed ID: 37307869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A family with PTEN mutations with malignancy and an unusually high number of offspring with autism spectrum disorder: a case report.
    Gruhl SL; Sharma P; Han TS
    J Med Case Rep; 2018 Nov; 12(1):353. PubMed ID: 30482242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
    Bubien V; Bonnet F; Brouste V; Hoppe S; Barouk-Simonet E; David A; Edery P; Bottani A; Layet V; Caron O; Gilbert-Dussardier B; Delnatte C; Dugast C; Fricker JP; Bonneau D; Sevenet N; Longy M; Caux F;
    J Med Genet; 2013 Apr; 50(4):255-63. PubMed ID: 23335809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN hamartoma tumor syndrome.
    Mester J; Charis E
    Handb Clin Neurol; 2015; 132():129-37. PubMed ID: 26564076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.
    Ngeow J; Eng C
    Methods; 2015 May; 77-78():11-9. PubMed ID: 25461771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
    Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V
    Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cowden syndrome.
    Gustafson S; Zbuk KM; Scacheri C; Eng C
    Semin Oncol; 2007 Oct; 34(5):428-34. PubMed ID: 17920899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers.
    Won HS; Chang ED; Na SJ; Whang IY; Lee DS; You SH; Kim YS; Kim JS
    Cancer Res Treat; 2019 Jan; 51(1):402-407. PubMed ID: 29510612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer.
    Shiovitz S; Everett J; Huang SC; Orloff MS; Eng C; Gruber SB
    Breast Cancer Res Treat; 2010 Nov; 124(2):459-65. PubMed ID: 20349131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.